Medicines and Healthcare products Regulatory Agency
| 1: Authorisation Number | UK MIA 3473 |
|---|---|
| 2: Name of authorisation holder | NHS NATIONAL SERVICES SCOTLAND |
| 3: Address(es) of manufacturing site(s) |
NHS NATIONAL SERVICES SCOTLAND, THE JACK COPLAND CENTRE, 52 RESEARCH AVENUE NORTH, HERIOT-WATT RESEARCH PARK, RICCARTON, CURRIE, EH14 4BE, UNITED KINGDOM |
| 4: Legally registered address of authorisation holder | NHS NATIONAL SERVICES SCOTLAND, THE JACK COPLAND CENTRE, 52 RESEARCH AVENUE NORTH, HERIOT-WATT RESEARCH PARK, RICCARTON, CURRIE, EH14 4BE, UNITED KINGDOM |
| 5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 |
| 6: Legal Basis of authorisation | |
| 7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential |
| 8: Authorisation Date | 16/09/2025 |
| 9: Annexes attached | Annex 1 and/or Annex 2 |
SCOPE OF AUTHORISATION
Annex 1
Name and address of the site:
NHS NATIONAL SERVICES SCOTLAND, THE JACK COPLAND CENTRE, 52 RESEARCH AVENUE NORTH, HERIOT-WATT RESEARCH PARK, RICCARTON, CURRIE, EH14 4BE, UNITED KINGDOM
Human Medicinal Products
| Authorised Operations |
| MANUFACTURING OPERATIONS (according to part 1) |
| Part 1 - MANUFACTURING OPERATIONS |
| [ 1.1 ] Sterile Products |
| [ 1.1.3 ] Batch certification |
| [ 1.3 ] Biological medicinal products |
| [ 1.3.1 ] Biological medicinal products |
| [ 1.3.1.2 ] Immunological products |
| [ 1.3.1.3 ] Cell therapy products |
| [ 1.3.1.8 ] Other biological medicinal products ATMPs as stipulated in 1394/2007 |
| [ 1.3.2 ] Batch certification |
| [ 1.3.2.2 ] Immunological products |
| [ 1.4 ] Other products or manufacturing activity |
| [ 1.4.1 ] Manufacture of: |
| [ 1.4.1.4 ] Products authorised under regulation 174 (supply in response to spread of pathogenic agents etc) |
| [ 1.5 ] Packaging |
| [ 1.5.2 ] Secondary packaging |